GSK3β Inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation

Journal of Investigative Dermatology

Volumn 132, Issue 12, 2012, Pages 2818-2827

  John, Jobin K ^a   Paraiso, Kim H T ^a   Rebecca, Vito W ^a   Cantini, Liliana P ^a   Abel, Ethan V ^b   Pagano, Nicholas ^c,d   Meggers, Eric ^c,d   Mathew, Rahel ^e   Krepler, Clemens ^f   Izumi, Victoria ^a   Fang, Bin ^a   Koomen, John M ^a   Messina, Jane L ^e   Herlyn, Meenhard ^f   Smalley, Keiran S M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FOCAL ADHESION KINASE 1; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NP 309; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; DOWN REGULATION; ENDOTHELIUM CELL; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; METASTATIC MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPHEROID CELL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84870515328     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.237     Document Type: Article

References (42)

1. Abel EV, Aplin AE (2010) FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells. Cancer Res 70:2891-900
2. Arozarena I, Bischof H, Gilby D et al. (2011) In melanoma, beta-catenin is a suppressor of invasion. Oncogene 30:4531-43
3. Atilla-Gokcumen GE, Pagano N, Streu C et al. (2008) Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3. Chembiochem 9:2933-6
4. Beasley G, Sanders G, Zager JS et al. (2011) A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma. J Clin Oncol 29:1210-5
5. Bhowmick NA, Chytil A, Plieth D et al. (2004a) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-51 (Pubitemid 38174665)
6. Bhowmick NA, Neilson EG, Moses HL (2004b) Stromal fibroblasts in cancer initiation and progression. Nature 432:332-7 (Pubitemid 39551661)
7. Camilli TC, Weeraratna AT (2010) Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem Pharmacol 80:702-11
8. Chien AJ, Moore EC, Lonsdorf AS et al. (2009) Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 106:1193-8
9. Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769-76 (Pubitemid 33679839)
10. Cross DA, Alessi DR, Cohen P et al. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-9 (Pubitemid 26004411)
11. Davies MA, Stemke-Hale K, Tellez C et al. (2008) A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99:1265-8
12. Diehl JA, Cheng M, Roussel MF et al. (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-511 (Pubitemid 28553242)
13. Eickholt BJ, Walsh FS, Doherty P (2002) An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol 157:211-7 (Pubitemid 34839818)
14. Flach E, Rebecca VW, Herlyn M et al. (2011) Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol Pharm 8:2039-49
15. Frame S, Cohen P (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16 (Pubitemid 32939202)
16. Gaggioli C, Hooper S, Hidalgo-Carcedo C et al. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9:1392-400 (Pubitemid 350201752)
17. Gartner A, Huang X, Hall A (2006) Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3beta) independently of Akt/PKB serine phosphorylation. J Cell Sci 119:3927-34 (Pubitemid 44650866)
18. Gupta PB, Kuperwasser C, Brunet JP et al. (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37:1047-54 (Pubitemid 41486656)
19. Haass NK, Smalley KS, Li L et al. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 18: 150-9 (Pubitemid 40733333)
20. Harris TJ, Tepass U (2010) Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol 11:502-14
21. He TC, Sparks AB, Rago C et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-12 (Pubitemid 28425575)
22. Hsu MY, Andl T, Li G et al. (2000a) Cadherin repertoire determines partnerspecific gap junctional communication during melanoma progression. J Cell Sci 113:1535-42 (Pubitemid 30312502)
23. Hsu MY, Meier FE, Nesbit M et al. (2000b) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156:1515-25 (Pubitemid 30646691)
24. Ilic D, Furuta Y, Kanazawa S et al. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539-44
25. Jacamo R, Jiang X, Lunn JA et al. (2007) FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration. J Cell Physiol 210:436-44 (Pubitemid 44956889)
26. Kobayashi T, Hino S, Oue N et al. (2006) Glycogen synthase kinase 3 and hprune regulate cell migration by modulating focal adhesions. Mol Cell Biol 26:898-911 (Pubitemid 43146485)
27. Koivisto L, Alavian K, Hakkinen L et al. (2003) Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes. J Cell Sci 116:3749-60 (Pubitemid 37185304)
28. Li G, Satyamoorthy K, Herlyn M (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61:3819-25 (Pubitemid 32694999)
29. Li G, Satyamoorthy K, Meier F et al. (2003) Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22:3162-71 (Pubitemid 36713768)
30. Lioni M, Brafford P, Andl C et al. (2007) Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 170:709-21 (Pubitemid 47342407)
31. Pagano N, Maksimoska J, Bregman H et al. (2007) Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand. Org Biomol Chem 5:1218-27 (Pubitemid 46546376)
32. Paraiso KH, Fedorenko IV, Cantini LP et al. (2010) Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy. Br J Cancer 102:1724-30
33. Paraiso KH, Xiang Y, Rebecca VW et al. (2011) PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res 71:2750-60
34. Qi J, Chen N, Wang J et al. (2005) Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the betacatenin signaling pathway. Mol Biol Cell 16:4386-97 (Pubitemid 41262905)
35. Shirley SH, Greene VR, Duncan LM et al. (2012) Slug expression during melanoma progression. Am J Pathol 180:2479-89
36. Smalley KS, Brafford P, Haass NK et al. (2005) Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 166:1541-54 (Pubitemid 40586522)
37. Smalley KS, Contractor R, Haass NK et al. (2007) Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer 96:445-9 (Pubitemid 46215215)
38. Smalley KS, Haass NK, Brafford PA et al. (2006) Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther 5:1136-44 (Pubitemid 43881305)
39. Stahl JM, Sharma A, Cheung M et al. (2004) Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64: 7002-10 (Pubitemid 39331010)
40. Tsao H, Goel V, Wu H et al. (2004) Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol 122:337-41 (Pubitemid 38281053)
41. Wu X, Shen QT, Oristian DS et al. (2011) Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3beta. Cell 144:341-52
42. Yost C, Torres M, Miller JR et al. (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10:1443-54 (Pubitemid 26260702)